Company Legal Name
Latest Valuation
Founded Year
Headquarter
RxSS operates a digital platform that enables consumers and health plans to identify lower-cost prescription drug alternatives. The Overland Park-based company addresses the growing need for prescription cost transparency in the healthcare market, providing tools that help users navigate complex pharmaceutical pricing structures. By connecting patients and insurers with affordable medication options, RxSS positions itself within the healthcare technology sector focused on cost reduction solutions. The platform serves both individual consumers seeking to reduce out-of-pocket expenses and health plans looking to optimize their prescription drug spending, targeting the intersection of healthcare accessibility and cost management.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





